IS5675A - Einsleitar lyfjasamsetningar sem samanstanda af abakavíri, lamivúdíni og zídóvúdíni - Google Patents

Einsleitar lyfjasamsetningar sem samanstanda af abakavíri, lamivúdíni og zídóvúdíni

Info

Publication number: IS5675A
Authority: IS; Iceland
Prior art keywords: abacavir; lamivudine; zidovudine; homogeneous formulations; formulations
Prior art date: 1998-04-29

Application number

IS5675A

Other languages

English (en)

Inventor

Currie Robin

Jain Sunil

Wayne Wood Allen

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-29

Filing date

2000-10-20

Publication date

2000-10-20

2000-10-20 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2000-10-20 Publication of IS5675A publication Critical patent/IS5675A/is

Links

LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
229960004748 abacavir Drugs 0.000 title 1
MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS5675A 1998-04-29 2000-10-20 Einsleitar lyfjasamsetningar sem samanstanda af abakavíri, lamivúdíni og zídóvúdíni IS5675A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9809213.3A GB9809213D0 (en)	1998-04-29	1998-04-29	Pharmaceutical compositions
PCT/EP1999/002794 WO1999055372A1 (en)	1998-04-29	1999-04-26	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Publications (1)

Publication Number	Publication Date
IS5675A true IS5675A (is)	2000-10-20

Family

ID=10831228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5675A IS5675A (is)	1998-04-29	2000-10-20	Einsleitar lyfjasamsetningar sem samanstanda af abakavíri, lamivúdíni og zídóvúdíni

Country Status (23)

Country	Link
EP (1)	EP1083932A1 (is)
JP (1)	JP2002512979A (is)
KR (1)	KR20010043128A (is)
CN (1)	CN1411380A (is)
AP (1)	AP2000001971A0 (is)
AU (1)	AU4135599A (is)
BR (1)	BR9910071A (is)
CA (1)	CA2330391A1 (is)
EA (1)	EA200000997A1 (is)
EE (1)	EE200000646A (is)
GB (1)	GB9809213D0 (is)
HR (1)	HRP20000732A2 (is)
HU (1)	HUP0101622A3 (is)
ID (1)	ID26955A (is)
IL (1)	IL139181A0 (is)
IS (1)	IS5675A (is)
NO (1)	NO20005418L (is)
NZ (1)	NZ507745A (is)
PL (1)	PL343710A1 (is)
SK (1)	SK16212000A3 (is)
TR (1)	TR200003157T2 (is)
WO (1)	WO1999055372A1 (is)
ZA (1)	ZA200005922B (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
EP1146882A2 (en) *	1998-05-29	2001-10-24	The University Of Florida	Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
EP1501521B1 (en) *	2002-04-23	2007-05-02	Lupin Limited	Long acting compositions comprising zidovudine and/or lamivudine
TW200403061A (en) *	2002-06-04	2004-03-01	Glaxo Group Ltd	Pharmaceutical compositions
CN100335125C (zh) *	2003-06-03	2007-09-05	上海现代药物制剂工程研究中心	杀毒抗菌用长效干扰素喷鼻粉剂
US20110104267A1 (en) *	2005-04-25	2011-05-05	Aurobindo Pharma Limited	Pharmaceutical compositions of antiretrovirals
US20070059360A1 (en) *	2005-07-29	2007-03-15	Ashish Jaiswal	Water-dispersible anti-retroviral pharmaceutical compositions
ES2279707B1 (es) *	2005-11-10	2008-06-01	Combino Pharm, S.L.	Formulaciones orales que comprenden 3'-azidonucleosidos.
BRPI0816498A2 (pt) *	2007-10-02	2019-02-26	Emory University	combinações potentes de zidovudina e drogas que selecionam para a mutuação k65r na polimerase do hiv
US20110117193A1 (en) *	2008-01-17	2011-05-19	Duquesne University Of The Holy Spirit	Antiretroviral drug formulations for treatment of children exposed to hiv/aids
RS54123B1 (sr)	2010-01-27	2015-12-31	Viiv Healthcare Company	Terapeutska kombinacija koja sadrži dolutegravir, abacavir i lamivudine
CN114010776A (zh)	2010-06-09	2022-02-08	疫苗技术股份有限公司	用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
RU2014140177A (ru)	2012-03-05	2016-04-27	Сипла Лимитед	Фармацевтические антиретровирусные композиции
MX364901B (es)	2012-10-23	2019-05-10	Cipla Ltd	Composicion farmaceutica antirretroviral.
CN114404414A (zh)	2013-06-13	2022-04-29	阿克比治疗有限公司	用于治疗贫血症的组合物和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY115461A (en) *	1995-03-30	2003-06-30	Wellcome Found	Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
1999
- 1999-04-26 EE EEP200000646A patent/EE200000646A/xx unknown
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/ja active Pending
- 1999-04-26 EA EA200000997A patent/EA200000997A1/ru unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 IL IL13918199A patent/IL139181A0/xx unknown
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/sk unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/ko not_active Withdrawn
- 1999-04-26 CN CN99807983A patent/CN1411380A/zh active Pending
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/hu unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/pt not_active IP Right Cessation
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/hr not_active Application Discontinuation
- 1999-04-26 PL PL99343710A patent/PL343710A1/xx unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 ID IDW20002479A patent/ID26955A/id unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/xx unknown
2000
- 2000-10-20 IS IS5675A patent/IS5675A/is unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/xx unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EE200000646A (et)	2002-04-15
AU4135599A (en)	1999-11-16
HRP20000732A2 (en)	2001-02-28
IL139181A0 (en)	2001-11-25
KR20010043128A (ko)	2001-05-25
ID26955A (id)	2001-02-22
AP2000001971A0 (en)	2000-12-31
NO20005418D0 (no)	2000-10-27
NZ507745A (en)	2004-07-30
CN1411380A (zh)	2003-04-16
CA2330391A1 (en)	1999-11-04
EA200000997A1 (ru)	2001-06-25
BR9910071A (pt)	2000-12-26
HUP0101622A3 (en)	2003-09-29
SK16212000A3 (sk)	2001-07-10
GB9809213D0 (en)	1998-07-01
PL343710A1 (en)	2001-08-27
EP1083932A1 (en)	2001-03-21
JP2002512979A (ja)	2002-05-08
WO1999055372A1 (en)	1999-11-04
ZA200005922B (en)	2001-10-23
NO20005418L (no)	2000-11-29
HUP0101622A2 (hu)	2002-03-28
TR200003157T2 (tr)	2001-01-22

Publication	Publication Date	Title
IS5675A (is)	2000-10-20	Einsleitar lyfjasamsetningar sem samanstanda af abakavíri, lamivúdíni og zídóvúdíni
NO20006520L (no)	2001-02-14	Adenosinderivater
DE59910409D1 (de)	2004-10-07	Distraktionsvorrichtung
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
ID23546A (id)	2000-05-04	Formulasi-formulasi ziprasidon
NO20004240L (no)	2000-10-18	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
DK1130966T3 (da)	2005-05-09	Antiparasitære formuleringer
PT1139761E (pt)	2003-10-31	Composicoes herbicidas e concentrados tensioactivos
ATE241597T1 (de)	2003-06-15	Geruchsmaskierte dimethylsulfid-zusammensetzung
DE69908455D1 (de)	2003-07-10	Kuvertiervorrichtung
DE69911530D1 (de)	2003-10-30	Härtbare Siliconzusammensetzung
NO20004160D0 (no)	2000-08-18	Langrenns- eller turskibinding
DE69936800D1 (de)	2007-09-20	Massenspektrometer
DE69840421D1 (de)	2009-02-12	Teilnehmerkontextes
NO20011358L (no)	2001-04-17	Antivirale kombinasjoner
ID27962A (id)	2001-05-03	Pembuatan tetrahidrofuran
DK1140068T3 (da)	2004-07-12	Doramectin formulations
DE59903011D1 (de)	2002-11-14	Kalibrierverfahren
ID26655A (id)	2001-01-25	Pembuatan streptokokus
ATA191299A (de)	2002-11-15	Beschichtungsmasse
DK1133300T3 (da)	2005-05-09	Desmethylolanzapinsammensætninger og fremgangsmåder
DE59811773D1 (de)	2004-09-09	Fesseldrachen
FI3527U1 (fi)	1998-08-13	Lumikenkä